[Federal Register Volume 60, Number 50 (Wednesday, March 15, 1995)]
[Notices]
[Pages 13998-13999]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-6289]
=======================================================================
-----------------------------------------------------------------------
GENERAL SERVICES ADMINISTRATION
Construction of FDA Regional Office and Laboratory; Environmental
Impact Statement; Jamaica, Queens County, New York
agency: General Services Administration (GSA).
action: Notice of Intent to hold a public scoping meeting and prepare
and file an Environmental Impact Statement (EIS).
-----------------------------------------------------------------------
summary: The GSA is issuing this notice to advise the public that an
EIS will be prepared for the construction of the FDA Regional Office
and Laboratory in Jamaica, Queens County, New York.
for further information contact: Mr. Peter A. Sneed, Asset Manager,
U.S. General Services Administration, Public Buildings Service, 26
Federal Plaza, Room 1609, New York City, NY 10278, (212) 264-3581.
supplementary information: The GSA will serve as lead agency and
project sponsor in the preparation and filing of an EIS for the
construction of the FDA Regional Office and Laboratory in Jamaica,
Queens County, New York. The proposed action would involve the
construction and operation of the facility on an assemblage of two
properties located at the intersection 158th Street and Liberty Avenue.
Combined, these two properties are 4.25 acres (1.73 hectares) in size.
The existing FDA regional facilities are located in Federal Building #2
of the Federal Complex in Sunset Park, Brooklyn, New York. Due to the
deteriorated condition of, and space constraints in, the present
facility, FDA has requested relocation to a modern expanded facility to
accommodate the additional staffing required to provide increased
oversight and product monitoring. This action is intended to provide
175,000 occupiable square feet (16,250 square meters) of office,
storage, and special space.
The EIS will evaluate the FDA regional facility alternatives,
including the No-Action Alternative. It will also evaluate impacts on
the affected environment, including, but not limited to,
socioeconomics, hazardous materials, traffic/transportation, land use,
cultural resources, and noise.
[[Page 13999]] public scoping meeting: To ensure that all issues
relating to the proposed project are identified and all potentially
significant issues are addressed and satisfied in the EIS, public
comments and suggestions are being solicited. To facilitate the receipt
of comments, a public scoping meeting will be held on Monday, March 20,
1995 from 2 p.m. to 4 p.m. and from 6 p.m. to 8 p.m. in the auditorium
of the Joseph Addabbo Federal Building, 1 Jamaica Center Plaza,
Jamaica, New York.
Written comments may be mailed to the informational contact person
no later than April 7, 1995.
Issued in New York City, New York on March 7, 1995.
Karen R. Adler,
Regional Administrator, General Services Administration, Region 2.
[FR Doc. 95-6289 Filed 3-14-95; 8:45 am]
BILLING CODE 6820-23-M
